ME Therapeutics Holdings Ratios and Metrics

Market cap in millions CAD. Fiscal year is September - August.

Millions CAD. Fiscal year is Sep - Aug.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 23, 2026	Aug '25 Aug 31, 2025	Aug '24 Aug 31, 2024	Aug '23 Aug 31, 2023	Aug '22 Aug 31, 2022	Aug '21 Aug 31, 2021
Market Capitalization	75	118	69	-	-	-
Market Cap Growth	-49.94%	70.86%	-	-	-	-
Enterprise Value	74	117	68	-	-	-
Last Close Price	2.50	4.00	2.75	-	-	-
PB Ratio	56.37	78.74	46.94	-	-	-
P/TBV Ratio	56.37	78.74	46.94	-	-	-
Debt / Equity Ratio	0.04	0.05	-	0.08	-1.46	-3.40
Debt / FCF Ratio	-	-	-	-	-	17.86
Net Debt / Equity Ratio	-0.89	-0.89	-1.01	-1.16	-0.88	0.74
Net Debt / EBITDA Ratio	0.90	1.07	1.09	0.62	-0.76	0.19
Net Debt / FCF Ratio	0.95	1.23	2.28	2.00	-0.85	-3.89
Quick Ratio	5.89	6.00	24.05	4.41	0.57	2.27
Current Ratio	5.99	6.12	24.45	4.52	0.59	2.27
Return on Equity (ROE)	-93.72%	-80.11%	-129.52%	-3327.53%	-	-2126.14%
Return on Assets (ROA)	-54.14%	-48.35%	-77.65%	-157.78%	-106.78%	-60.78%
Return on Capital Employed (ROCE)	-101.20%	-84.30%	-93.10%	-186.70%	212.60%	-167.10%
Earnings Yield	-1.66%	-1.01%	-1.87%	-	-	-
FCF Yield	-1.66%	-0.91%	-0.95%	-	-	-
Buyback Yield / Dilution	-16.94%	-14.17%	-55.90%	-84.08%	-39.53%	-0.07%

Updated Nov 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.